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Abstract
Background: An increasing number of children are suffering from brain damage-related visual processing
dysfunctions (VPD). There is currently a lack of evidence-based intervention methods that can be used early in
development. We developed a visual intervention protocol suitable from 1 year of age. The protocol is structured,
comprehensive and individually adaptive, and is paired with quantitative outcome assessments. Our aim is to
investigate the effectiveness of this first visual intervention program for young children with (a risk of) VPD.
Methods: This is a single-blind, placebo-controlled trial that is embedded within standard clinical care. The study
population consists of 100 children born very or extremely preterm (< 30 weeks) at 1 year of corrected age (CA), of
whom 50% are expected to have VPD. First, children undergo a visual screening at 1 year CA. If they are classified
as being at risk of VPD, they are referred to standard care, which involves an ophthalmic and visual function
assessment and a (newly developed) visual intervention program. This program consists of a general protocol
(standardized and similar for all children) and a supplement protocol (adapted to the specific needs of the child).
Children are randomly allocated to an intervention group (starting upon inclusion at 1 year CA) or a control group
(postponed: starting at 2 years CA). The control group will receive a placebo treatment. The effectiveness of early
visual intervention will be examined with follow-up visual and neurocognitive assessments after 1 year (upon
completion of the direct intervention) and after 2 years (upon completion of the postponed intervention).
Discussion: Through this randomized controlled trial we will establish the effectiveness of a new and early visual
intervention program. Combining a general and supplement protocol enables both structured comparisons
between participants and groups, and custom habilitation that is tailored to a child’s specific needs. The design ensures
that all included children will benefit from participation by advancing the age at which they start receiving an
intervention. We expect results to be applicable to the overall population of children with (a risk of) VPD early in life.
Trial registration: Netherlands Trial Register: NTR6952. Registered 19 January 2018.
Keywords: Visual intervention, Visual habilitation, Cerebral visual impairment, Neurological risk, Eye tracking, Visual
attention, Visual processing, Brain damage, Children born preterm
© The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: m.kooiker@erasmusmc.nl
ˆKees Kuyper is deceased. This paper is dedicated to his memory.
1Department of Neuroscience, Erasmus Medical Center, PO Box 2040, 3000,
CA, Rotterdam, The Netherlands
Full list of author information is available at the end of the article
Kooiker et al. Trials           (2020) 21:44 
https://doi.org/10.1186/s13063-019-3936-9
Background
Over the past decades, survival rates of children with
neurodevelopmental disorders or who experienced ad-
verse perinatal events (e.g., preterm birth, hypoxia/ische-
mia, cerebral hemorrhages) have increased due to the
intensive, high quality care that they receive. As a conse-
quence, the prevalence of children with brain damage
has also increased. Since approximately 40% of the brain
is involved in processing visual information, there is a
high likelihood that these children will develop visual
dysfunctions. Visual dysfunctions with a cerebral origin
are generally called cerebral visual impairments (CVI)
and have become common in children – conservative
estimates range from 10 to 22 cases per 10,000 births in
developed countries, to 40 per 10,000 births in develop-
ing countries [1]. CVI are now the primary cause of low
vision in children [2, 3]. The visual system consists of an
extensive network that involves both ocular and subcor-
tical structures and numerous brain areas, including
higher-order parietal and frontal areas. Consequently,
children with brain damage-related visual impairments,
or CVI, are a heterogeneous population that can suffer
from a variety of problems – from lower-order visual
sensory and oculomotor deficits, to higher-order visual
perception difficulties. What they have in common on a
functional level are challenges with detecting, attending
to and processing incoming visual information, i.e., vis-
ual processing dysfunctions (VPD). VPD include issues
with orienting and maintaining visual attention, detect-
ing and perceiving specific visual features (e.g., colors,
forms, motion) as well as with giving meaning to what is
perceived and using the visual input for behavior. These
visual processing functions can be considered prerequi-
sites for higher-order visual perception functions, e.g.,
visual recognition and visuospatial orientation. Unlike
such perception problems, which cannot reliably be
assessed before school age, signs of VPD can be detected
at earlier developmental stages. Given that early visual
dysfunctions can severely delay or disrupt neurocogni-
tive, motor and behavioral development [4–6], VPD
particularly affect young children.
To alleviate early-onset problems, prevent later
growing-into-deficit, and maximize developmental op-
portunities, detection and habilitation of VPD early in
life is crucial [7, 8]. Early in development, high levels of
cerebral plasticity may enable recovery or take-over of
function on a structural level, whereas early and diverse
visual experiences may enhance visual development on a
functional level. Therefore, it is assumed that the sooner
visual habilitation programs start, the higher the likeli-
hood that they will stimulate and improve visual pro-
cessing development. Although there are a large number
of infant studies regarding early detection of visual dys-
functions that rely on this assumption, the effectiveness
of early interventions in the visual domain has never
been proven.
Early habilitation starts with early detection. Before
the age of 4–5 years, it used to be challenging to assess
the functional consequences of damage to the brain’s
visual system. There have been advances in the early de-
tection of (a risk of) visual problems, for example, the
early assessment of basic visual function in neonates as
early as 31 weeks of gestation [9] and a functional vision
battery with cognitive and integrative aspects for use be-
tween 1 and 4 years of age [10]. These batteries involve
various aspects of visual function and rely on behavioral
observations. In addition, more quantitative, computer-
based methods have been developed such as an eye
tracking-based task for attention in toddlers [11]. Build-
ing on these innovations, our group developed a method
to quantify visual processing efficiency in a non-verbal
manner in children, using an eye tracking-based ap-
proach [12, 13]. We showed that children with (a high
risk of) brain damage or dysfunction (e.g., children with
visual disorders or children born extremely preterm) are
prone to developing VPD [14–16]. These VPD were par-
ticularly strongly correlated with diagnosed CVI [17, 18].
These innovative early and non-verbal assessments can
fulfill the need for scientifically strong psychometric
tools to evaluate the effectiveness of early intervention.
Besides providing an early characterization of VPD that
was previously unavailable, they also open up the possi-
bility to monitor or habilitate VPD at a young age. One
can even argue that early detection of problems is only
useful if it leads to advancing support and habilitation.
Hence, the essential next step in the field of pediatric
visual dysfunctions is to provide affected children with
effective early intervention programs.
A major problem is that there is no evidence-based
intervention for VPD from 1 year of age – this area is
severely understudied [19] and quality of evidence is low
[20–22]. Available (visual) interventions lack a standard-
ized approach and/or systematic objective evaluation [23–
25], and ideas about their effectiveness merely stem from
clinical impressions, not from randomized and carefully
controlled studies. The available evidence has predomin-
antly been found in older children, for a limited range of
visual functions (i.e., visual acuity and/or contrast sensitiv-
ity) [26], without incorporation of functional vision mea-
sures, using only stimulation and no training [24, 26], and
without objective outcome measures. Studies that did use
a comprehensive and structured training approach had a
small sample size [27, 28]. Although these existing studies
provide important information on the approaches and
possibilities to habilitate visual problems, the effectiveness
of visual intervention programs for children younger than
4 years has not yet been investigated with a randomized
controlled trial (RCT).
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VPD in children can arise from many different condi-
tions, e.g., perinatal asphyxia or hypoxia, focal lesions,
cranial trauma, infections, or hemorrhages. Therefore,
the general population with VPD is a highly heteroge-
neous group of children. In the present study, we focus
on children born very or extremely preterm (i.e., born <
30 weeks of gestation) from 1 year of corrected age (CA).
In an ongoing longitudinal study, we found elevated
risks of visual attention and processing problems in this
population [15, 16], driving the urgency for interven-
tions. However, we expect outcomes to be applicable to
other young children at risk of brain damage-related
VPD. After positive results have been obtained, the vis-
ual intervention program can be investigated in other
risk groups.
The aim of this study is to investigate the effectiveness
of early intervention of VPD in children born very or
extremely preterm from 1 year CA. To this end, we
developed a structured yet individually tailored visual
intervention protocol. We will test its effectiveness in
enhancing visual development with a RCT. Unique
features of the presented approach are the objective
outcome measures assessed from a young age, broad
quantitative and qualitative data collection to assess the
full spectrum of visual functions and neurodevelopment,
and embedding of the project within standard neonatal
and visual clinical care. This protocol was written in
accordance with the Standard Protocol Items: Recom-
mendations for Intervention Trials (SPIRIT) guidelines.
Additional file 1 contains the SPIRIT checklist.
Methods
Study design
Randomized single-blind, placebo-controlled interven-
tion study (RCT), embedded within standard clinical
care.
Study setting
The study will be executed at the Neonatology Depart-
ment of an academic medical center, in collaboration
with the Department of Pediatric Ophthalmology and
with four regional centers of a center of expertise for
blind and partially sighted people that provides visual
diagnostics and (re)habilitation.
Participant characteristics and timeline
It is expected that 25–50% of the very preterm popula-
tion is at risk of VPD at 1 year CA [15, 16]. Therefore,
all infants who have been born before 30 weeks gesta-
tional age and who participate in the clinical follow-up
program of the Department of Neonatology, will be
available for inclusion around 1 year CA. We aim to in-
clude children from 1 year CA, born < 30 weeks of gesta-
tion (about 50% are expected to be at risk of VPD, and
eligible for the intervention) (n = 100) and children born at
term without VPD from 1 year of age, to add to an existing
database of typically developing children (healthy control
group) (n = 100). The study population will be divided into
three groups, with two subgroups – Group 1: children
born very preterm from 1 year CA, without a risk of VPD;
Group 2: children born very preterm from 1 year CA, with
a risk of VPD (50% will receive direct visual intervention
(group 2A, intervention group) and 50% will receive post-
poned visual intervention (group 2B, control group);
Group 3: children born at term without a risk of VPD.
Eligibility criteria
Inclusion criteria
 Born < 30 weeks gestational age
 Age at inclusion of 1 year CA (+/− 2 months)
Exclusion criteria
 Visual acuity below 0.05 (Snellen equivalent); the visual
screening (i.e., eye tracking-based exam) is designed to
be visible with a visual acuity of 0.05 or higher
 High chance of epileptic activity during assessment;
more than two attacks in the previous year or when
using the anti-epileptic vigabatrin (which may lead
to visual dysfunction)
 Retinopathy of prematurity of grade 3 or higher,
assessed by a pediatric ophthalmologist, as this will
account for their visual dysfunction
Study procedures
Figure 1 outlines the general time schedule of the study.
Figure 2 outlines the flow of assessments and interven-
tions for study participants.
Participant inclusion and baseline screening
Children born at < 30 weeks gestational age will be re-
cruited around the CA of 1 year at the Department of
Neonatology of an academic medical center. After
obtaining written informed consent (Additional file 2), a
visual screening is performed to identify the prevalence
and nature of VPD (for details, see ‘Data collection
methods’). The first part of the screening consists of an
eye tracking-based assessment of visual attention and
processing. The visual assessment results are compared
to normative references to identify the children with a
risk of VPD. The second part of the screening is a
checklist to identify common neurological risk factors
for VPD, and that is completed by the neonatologists.
Children who are identified as being at risk of VPD
will first undergo an orthoptic and ophthalmic exam at
the Department Pediatric Ophthalmology (including re-
fraction, ocular alignment). Next, they will be referred to
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a visual advisory and rehabilitation center in order to re-
ceive standard care, consisting of a visual function as-
sessment (VFA) and a visual intervention program. The
VFA is used to evaluate visual sensory functions (e.g.,
visual acuity, visual field, contrast sensitivity, ocular
motility) and to observe the functional visual behavior of
the child. This assessment is performed by experienced
orthoptists, optometrists and behavioral therapists, and
together they will determine the visual level of the child
[5, 29] according to the following categories:
A. Profound visual dysfunction/legally blind (mainly
responding to light)
B. Severe visual dysfunction, passive attentional system
(reactions to stimuli do not reach normative levels,
child does not actively search for visual stimulation,
low recognition)
C. Moderate visual dysfunction/basic perception (active
visual attention system and basic visual recognition)
D. Mild visual dysfunction, subnormal visual function
(functioning at the lower bound of normal)
Intervention
For a detailed outline of the visual rehabilitation
protocol we refer to the section ‘Intervention: a
visual habilitation protocol’ and to Additional file 3:
template visual intervention protocol. To reliably
examine the effectiveness of the visual intervention
program with an RCT, children who are at risk of
VPD will be randomly allocated to one of two
groups, as follows:
1. Intervention group (direct)
This group consists of very preterm children who are
at risk of VPD and who will start the visual intervention
program upon referral to the visual rehabilitation center
(i.e., around 1 year CA). The program consists of a gen-
eral protocol (standardized across participants) and a
supplement protocol (tailored to the child’s specific
VPD), and lasts ~ 1 year.
2. Control group (postponed and placebo)
Fig. 1 Time schedule of enrolment, interventions, and assessments
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This group consists of very preterm children who are
also at risk of VPD, but for whom the visual intervention
program will be postponed for the duration of 1 year.
These children will be placed on a waiting list for the
duration of the direct visual intervention (i.e., ~ 1 year).
During this first year, they will receive a placebo
intervention involving general developmental support
that is aimed at monitoring the child’s developmental
progress without providing specific visual habilitation.
As soon as the follow-up assessments of the direct
intervention group are completed, children in the
control group will start visual intervention (i.e.,
around 2 years CA).
Importantly, this study design ensures that all children
at risk of VPD will receive visual intervention at an earl-
ier age than is the case in current standard care (i.e.,
where only a small number of young children will be re-
ferred based on obvious ocular disorders, and others will
not receive interventions before the age of 4–6 years),
while the RCT design enables a reliable and controlled
comparison of the effectiveness of visual intervention
within this group.
Follow-up after 1 year
One year after inclusion, the children at risk of VPD will
repeat the visual function assessments, and all included
children (with and without VPD risk) will repeat the eye
tracking-based visual screening and undergo a neurode-
velopmental assessment (that is standard care at most
Neonatology departments, from 2 years CA). That way,
the specific effects of early visual intervention on visual
Fig. 2 Flow diagram
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processing and neurocognitive development are com-
pared and evaluated.
Postponed intervention
After the first follow-up, the children in the postponed
intervention group will start their visual intervention
program, which will also be evaluated 1 year later. In
addition, the results of the visual screening are again
evaluated for all children, to identify new cases with a
risk of VPD who will then also qualify to start visual
intervention. Differences in effectiveness of direct and
postponed early visual intervention are assessed. The
intervention study will have a duration of either 1 or 2
years, depending on the visual intervention group.
Data collection methods
Baseline (T0)
Medical and demographic information will be extracted
from the medical records available at the academic
medical center.
Visual screening – A0 All included children will be
screened for a risk of VPD, which consists of (1) an eye
tracking-based assessment and (2) a neurological check-
list. The eye tracking-based assessment is used to meas-
ure visual attention and processing functions. The
assessment will be combined with an existing appoint-
ment for standard outpatient visits at the Neonatology
Department when the child is ~ 1 year CA (T0) and 2
years CA (T1). During this assessment, children sit in
front of the eye tracker monitor at a distance of approxi-
mately 60 cm, either independently, on the lap of their
parent or in a pram. They do not receive verbal instruc-
tions and their body and head position is not restricted.
The assessments are conducted in a quiet room with
ambient light conditions. Visual stimuli (images and
movies) are presented on the monitor to engage the re-
flexive orienting eye movements of the child, while sim-
ultaneously the eye positions are recorded over time
using infrared cornea reflection (Tobii T60 XL or Tobii
X3, Tobii Corporation, Danderyd, Sweden). That way,
the child’s eye movement responses to various types of
visual information (i.e., contrast, color, motion and
form) are automatically recorded. These viewing behav-
ior responses indicate whether and how fast a specific
stimulus was detected and looked at. From these re-
sponses, the number of detected stimuli and the reaction
time to fixation (RTF) of a stimulus are calculated. RTF
is a measure for the timing of detecting and processing
visual information and is the main study parameter [12,
13, 30, 31]. Total test duration is approximately 15 min.
The child’s viewing behavior parameters per visual
stimulus are analyzed and compared with normative
data, i.e., developmental trajectories of an existing
database of healthy control children, born at term to
identify abnormal detection and timing of processing of
the visual stimuli. This results in a classification of nor-
mal and abnormal visual attention and processing
functions.
Second, medical specialists examine the child’s medical
history for the presence of neurological risk factors for
VPD in the context of prematurity [32–35], i.e.,
moderate-severe damage on neonatal MRI scans; cere-
bral palsy, unilateral/bilateral hemiplegia/diplegia; infant-
ile esotropia/convergent strabismus or nystagmus; and
deviating head circumference (> 1 SD in 12months).
Inventories for daily life visual functioning – B0 The
Participation and Activities Inventory – Children and
Youth (PAI-CY) 0–2 questionnaire [36] will be filled in
by parents upon inclusion. This questionnaire assesses
daily visual functioning in seven domains. Originally de-
veloped as a list to identify participation and activity
needs, it can also be used to investigate and monitor
intervention needs of visually impaired young children.
It is the only available patient-reported visual outcome
measure for young children and has satisfactory psycho-
metric properties [37].
Determining the risk of VPD The risk of VPD is deter-
mined based on the baseline screening: abnormal view-
ing behavior, indicated by abnormal RTF values on one
or more visual stimuli and/or the presence of at least
one neurological risk factor for VPD. The children at
risk of VPD are referred to standard care for children
with suspected visual dysfunctions, i.e., they will undergo
an ophthalmic exam to evaluate eye and orthoptic func-
tion and they will become clients of the visual advisory
and rehabilitation center where they undergo a visual
function assessment and are enrolled in the visual inter-
vention program.
Ophthalmic exam (standard care; group 2A and 2B)
– C0 All children at risk of VPD will be referred to the
Pediatric Ophthalmology Department to evaluate visual
acuity, refractive error and ocular alignment. This evalu-
ation is performed by ophthalmologists and/or research
orthoptists. The total duration of the exam is approxi-
mately 1 hour.
VFA, (standard care, groups 2A and 2B) – D0 All
children at risk of VPD will undergo an extensive VFA.
This assessment is part of standard care and will be
done by an experienced orthoptist or optometrist. All as-
sessments will be performed according to a standardized
protocol that ensures similar assessments, choice of tests
and scoring by the various examiners. The following
functions will be assessed: ocular alignment and fixation
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preference, binocular vision, presence of nystagmus,
oculomotor function (fixation, saccades, pursuit, motil-
ity), convergence, visual acuity, visual field, contrast sen-
sitivity and color vision. Performance per function is
classified as normal or abnormal for the child’s age.
First follow-up (T1)
Starting at 1 year after inclusion, i.e., from 2 years CA,
the following assessments are repeated:
Visual screening (study-specific; all groups) – A1 The
visual assessment (eye tracking-based exams) will be re-
peated for all included children and will be combined
with an existing appointment for standard outpatient
visits at the Neonatology Department.
Inventory for daily life visual functioning (study
specific) – B1 Parents are asked to complete the inven-
tory again around the time of first follow-up.
VFA (standard care) – D1 The VFAs will be repeated
in the children at risk of VPD (independent of the visual
intervention group they are in), as part of standard care
at the visual advisory center.
Neurodevelopmental assessment (standard care) – E
From 2 years CA, all children will receive a neurodeve-
lopmental assessment at the NICU as part of the stand-
ard follow-up program of the Department of
Neonatology. This assessment consists of the Bayley
Scales of Infant and Toddler Development (Bayley-III-
NL) and is performed by experienced
(neuro)psychologists.
Second follow-up (T2)
Two years after inclusion, i.e., from 3 years CA, all in-
cluded children will repeat the eye tracking-based visual
screening (A2) and the inventories for daily life visual
functioning (B2). Since at 3 years CA there is no regular
follow-up within clinical care, study-specific appoint-
ments will be made at the academic hospital or in the
form of home visits. In addition, the children at risk of
VPD who have been referred to the visual advisory cen-
ter will undergo the VFA again (D2) as part of standard
care.
By embedding the majority of this study within stand-
ard clinical care, by closely collaborating with involved
medical and visual (re)habilitation specialists, and by
planning participation together with regular appoint-
ments or in the form of home visits, we expect to
maximize participants’ completion of the follow-up
measurements.
Intervention: visual habilitation protocol (Additional file
3)
We developed a structured visual intervention protocol
using a two-step approach – (1) dissecting available sci-
entific knowledge about visual interventions in young
children and (2) establishing other, clinically relevant,
factors in close collaboration with experienced behav-
ioral therapists and neuropsychologists.
First, based on the available (visual) intervention litera-
ture, we extracted several key features for the interven-
tion, thus constructing a protocol with the following
characteristics:
1) Starts well before school age to maximize
experience-dependent neuroplasticity [38, 39]
2) Involves the total spectrum of visual development,
not restricted to only a few visual functions [40] or
general neurodevelopment [41]
3) Has quantitative and functional outcomes [23, 28]
4) Employs two intervention strategies that have
complementary value [20, 27]:
a. Passive (bottom-up-feedforward) visual
stimulation that is purposeful and specific
[42–44]
b. Active (top-down modulated) visual perceptual
training that is contingent on children’s abilities
[28, 43, 45]
5) Can be individually tailored by adapting materials
and activities to children’s preferences and
capabilities [25]
6) Incorporates children’s systems through active
caregiver involvement [38, 46]
Second, we examined the clinical and practical re-
quirements for an intervention protocol by consulting
professionals about which types of habilitation to in-
clude, in which (developmental) domains, which ele-
ments, materials and objects to use, minimum duration
and frequency, and how to handle parental motivational
and resistance issues. The answers to these questions
were grouped and analyzed in order to extract common
themes and select the most important clinical features
the protocol should contain.
The result of this two-step process is a visual interven-
tion program that consists of:
1. A general protocol that is identical for all children
2. A supplement protocol that is tailored to the
specific VPD of the child.
Both parts are designed to adhere to the child’s basic
visual skills and to their cognitive, motor and socioemo-
tional developmental level. Importantly, the parent–child
relationship will be taken into account in order to
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support, involve and stimulate the parents in executing
the intervention program at home.
The general visual protocol is adapted to the child’s
age and developmental level and consists of exercises fo-
cused on the following functions: fixation, pursuit, visual
attention, enhancing visual experiences and knowledge,
perception of details and combining vision with motor
action (visuomotor skills). The intervention program
consists of several steps that can be applied to all
functions:
 Enhancing the diversity of training with different
visual materials
 Enhancing the duration of visual training
 Developing increasingly complex visual skills and
behavior that are ecologically valid, i.e., related to
the child’s activities and daily environment [20].
Visual input is provided in the form of different visual
materials of different visual modalities (colors, black-
white, moving and static objects, light and dark). The
nature of visual input will be adapted to the preferences
and abilities of the child, and successful responses and
behavior will be rewarded (based on operant condition-
ing). Visual training of more complex skills and behavior
is done by teaching the child to use a specific visual skill,
to expand its use to other tasks and to integrate it in
everyday life.
The supplement visual protocol is designed around
the specific VPD that are determined based on results
of the visual screening and assessments (VFA and ob-
servation) performed at baseline. For example, chil-
dren with abnormal processing of form and motion
information, but with normal processing of contrast
and color information, will get additional training for
the processing of form and motion-related visual in-
formation that is integrated within the visual inter-
vention program itself in order to comprehensively
support the child.
Additional components:
– Focus moments. These therapy sessions with video
feedback, evaluation with the parents and reports of
behavioral observations, are done three times
throughout the intervention period to determine
whether the program suffices or needs adaptations.
– Stepping cards (per therapy session). An instruction
for the daily practice sessions of parents that
contains a specific goal, instruction, observational
points, and evaluation.
– Logbook for therapists (per session) and parents (to be
completed weekly). The logbooks are used to keep track
of the frequency, intensity and content of the therapy
sessions and the daily practice sessions by parents.
– Protocol for Activities & Materials to be used, based
on chapter 5 [29]
Criteria for discontinuing or modifying interventions
Modifying the intensity of intervention: after the second
focus moment (around week 16), it will be determined
whether the child will still benefit from weekly sessions
or could have these every 2 weeks. If this intervention
intensity is no longer needed, the intensity is brought
down to once every 4 or 6 weeks, to keep monitoring
(visual) development, and to enable another frequency
adaptation when needed. This will be done until the end
of the program.
Modifying the content or focus of rehabilitation: this is
based on the evaluations with parents and the observa-
tions after each therapy session. If a modification is war-
ranted, only the supplement protocol will be modified,
the standard protocol will not change.
Improving and monitoring intervention adherence
All intervention activities are demonstrated and ex-
plained to the parents by the therapists. The goal is to
have them understand the content of activities and the
underlying motivation, to stimulate parents to practice
daily with their child. Parents will participate in all
therapy sessions – they do not only receive practice in-
structions but will also be educated on the visual devel-
opment of their child. The parents are asked to log their
daily practice session in order to evaluate them in the
therapy sessions. These evaluations will give insights in
improvements and/or changes in visual performance of
the child, which is known to motivate parents and
enhance intervention adherence.
Permitted concomitant care
Participating children will not be restricted in receiving
care as usual. If applicable, they are allowed to engage in
additional neurodevelopmental training programs during
this study. However, participation in such programs will
be carefully registered and monitored to consider inter-
ference with the possible effects of the visual interven-
tion program. In addition, children in the control
intervention group will be provided with general devel-
opmental support and monitoring that does not include
specific visual training components. This program con-
sists of visits by a psychologist-in-training (under super-
vision of neuropsychologists from the academic hospital
and visual advisory center) and aims at monitoring de-
velopmental achievements of preterm children from 1 to
2 years of CA. That way, we directly involve all parents
in the study, and enable a structured and controlled in-
vestigation of the effectiveness of specific visual habilita-
tion. After concluding the study, the children who are at
risk of VPD and have been referred to the visual
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rehabilitation center will continue to be monitored there.
This means that their treatment does not necessarily
stop, but that this depends on the indications and judge-
ment of the therapists and psychologists.
Outcome measures
To answer our main research question about the effect-
iveness of early visual intervention in young preterm
children, we will compare visual outcomes between the
intervention and control group. We will analyze results
from the eye tracking-based visual assessment and the
additional VFAs at baseline and at yearly follow-up mea-
surements. Primary outcomes are the changes in visual
parameters after the duration of the intervention study
(i.e., from baseline to follow-up T1 and/or T2), namely
quantitative visual parameters (eye tracking-based visual
detection and viewing reaction times) and VFA (visual
acuity, contrast sensitivity, visual field, ocular motility).
Endpoints are the changes in these parameters after
the visual intervention program. These parameters are
chosen since their combination provides quantitative
and objective results about functional viewing behavior
(the eye tracking-based assessment) and clinically rele-
vant visual function outcomes (i.e., the VFAs). In
addition, we will compare the effectiveness of direct (at
1 year CA) versus postponed visual habilitation (at 2
years CA) by comparing visual outcomes between these
groups at T2.
Secondary outcomes are the neurodevelopmental level
at the first follow-up (T1) and results from parental
questionnaires about daily visual functioning at T1 and/
or T2, i.e., total score, cognitive and motor sub scores of
the neurocognitive assessment with Bayley Scales of In-
fant and Toddler Development (Bayley-III-NL) and total
score and sub scores per visual domain of the PAI-CY
0–2 Inventory (i.e., attachment, stimulus processing,
orientation, play, mobility, communication). These mea-
sures were chosen because Bayley-III-NL is the only
available neurocognitive assessment for children at this
age, and the PAI-CY 0–2 Inventory is the only available
parental questionnaire about daily (visual) behavior at
this age.
Sample size calculation
Each year, approximately 200 children are born before
30 weeks of gestation and admitted to the Neonatal
Intensive Care Unit at the academic medical center in
Rotterdam, the Netherlands. Based on previous research
with this population we expect an inclusion rate of ~ 50%.
Therefore, we expect to include at least 100 children at 1
year CA. There are no thorough estimates of the preva-
lence of VPD in preterm children. A previous study using
the eye tracking-based assessment in extremely preterm
children identified visual processing delays in 48% of
preterm children without evidence for brain damage [16],
and in 9% to 23% of children in a cross section of the pre-
term population at 1 year CA [15]. In addition, between
25% and 33% of children with CVI have prematurity as a
contributing factor [32]. However, the prevalence of risk
factors for VPD in our study population (often with brain
damage and perinatal events) is much higher than 50%.
Therefore, we expect that each year at least 50 newborn
preterm children from the Neonatology Department (i.e.,
50%) are at risk of VPD and thus eligible for inclusion in
the intervention study.
Recruitment strategies
Children will be recruited from a medical follow-up pro-
gram for children born preterm that is ongoing at the
Department of Neonatology. Children’s eligibility for in-
clusion will be screened by a multidisciplinary team
(project leader and project members from Neonatology).
The project leader and/or project members will
approach their parents first by telephone, to ask for
permission to send an information leaflet about the
study. Two weeks after sending the study information,
parents will be contacted again to ask for their
permission to include their child in the study. The
baseline assessment (i.e., the visual screening) and the
1-year follow-up assessment will be scheduled to-
gether with an existing appointment at Neonatology,
to minimize burden for children and parents. Chil-
dren in the control group (group 3) will be recruited
through daycare centers. The parents will receive
study information by mail and are asked to contact
the project leader if they are willing to participate. If
they give their consent, an appointment for the visual
assessment will be made.
Randomization and intervention allocation
Prior to recruitment of participants, a randomization
scheme has been designed in which the order of visual
intervention groups (either direct or postponed) is ran-
domized using an online tool (Sealed Envelope Ltd.
2016; https://www.sealedenvelope.com/simple-randomi-
ser/v1/lists).
Randomization is blocked to ensure a balance in sam-
ple size across groups over time and stratified to control
and balance the influence of covariates [47]. Covariates
in the current study are the presence of brain damage
and gestational age (< 28 weeks or 28–30 weeks).
After this computer-generated randomization, preterm
children who are classified as being at risk of VPD will
be assigned a participant number and concurrently be
allocated to one of the visual intervention programs.
The order of allocation corresponds with the date and
order of inclusion. This allocation will be done by the
principal investigator and remains concealed to all other
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investigators, the participating children, and their par-
ents. All participant numbers will be separately placed in
opaque envelopes that contain a note with the assigned
visual intervention group. Revealing the group allocation
to parents will be done by opening the opaque envelopes
in their presence.
Blinding
The study set-up is single-blind. Intervention allocation
will be known by the project leader managing the con-
tacts between all involved parties, and by the behavioral
therapists of the visual rehabilitation center who will
perform the interventions. Parents cannot be blinded to
intervention allocation either, as they will actively par-
ticipate in the intervention programs. However, the allo-
cation will be blinded for the researchers and orthoptists
who perform the baseline and follow-up visual assess-
ments, and for the researchers performing data analyses.
Prior to analyzing results of the visual intervention
(i.e., analyzing results of the follow-up visual assess-
ments), participant numbers will be converted into a
new participant code and visual intervention group will
be coded into a new variable (group A or B). That way,
group allocation remains concealed and bias during data
analysis will be prevented [48].
Data management
All data will be handled confidentially and anonymously.
Communication about participating children between
the various participating departments and organizations
will only be done using codes, not names or other per-
sonal identifying information. All data will be coded, and
a separate coding list will link study data to personal
identifying information of a specific subject. The coding
list is password-protected and only accessible by the
main investigator(s). Data files will be stored on a PC
and will be accessible with a password that is only
known to the main investigator(s). Paper documents will
be stored in a locked cupboard of which only the main
investigator(s) will have a key. The investigator(s) will
remain blind to the participants’ outcomes during the
course of the study. All data will be anonymized prior
to analyses and publications. Group allocation and
randomization will not be revealed until after the
statistical analyses have been finished.
Withdrawal
Parents and their children can withdraw from the study
at any time for any reason if they wish to do so without
any consequences. The investigator can decide to
withdraw a subject from the study for urgent medical
reasons. When subjects withdraw from the visual inter-
vention program they will not be replaced in order to
ensure adherence to the randomization protocol for the
RCT. Withdrawal of subjects will be taken into account
during data analyses by using intention-to-treat analyses.
Subjects withdrawn from the visual intervention pro-
gram will be followed-up with a short questionnaire
(assessed by telephone) in which they are asked for their
reasons and circumstances of their withdrawal.
Statistical analyses
Sample size calculation
To answer our primary research question about the
effectiveness of early visual intervention programs on
visual attention and processing functions in preterm
children at risk of VPD, we use a repeated measures
analysis of variance (ANOVA) for the parameter RTF as
primary analysis. An a priori power analysis provided a
recommended total sample size of 32 children (and an
actual power of 0.81 and a critical F of 4.17).
Effectiveness of visual intervention program
In children at risk of VPD who have been allocated to a
visual intervention group, differences in viewing behav-
ior parameter RTF between T0 and T1 are analyzed with
a Repeated Measures ANOVA. A p value of 0.05 will be
considered statistically significant. Covariates are the
medical (perinatal and ophthalmic) and demographic
factors and the repeated measures analyses will be done
with and without them to obtain their contribution to
the main effect. All analyses are done according to the
intention-to-treat principle.
Other effects of visual intervention on VPD (other
parameters)
Secondary study parameters are the differences in other
eye tracking-based parameters of viewing behavior and
the outcomes of VFAs (e.g., visual acuity, contrast sensi-
tivity, extent of visual field). Repeated measures ANO-
VAs with a P value of 0.05 will be considered statistically
significant. After finding a main effect of group on the
viewing behavior parameters, post-hoc comparisons will
be done to establish which of the five visual stimuli sig-
nificantly differ from each other in parameter values. For
these comparisons, Bonferroni’s correction will be ap-
plied to the viewing behavior variables to correct the P
value for the number of comparisons.
Effects of visual intervention on neurodevelopment
At 2 years of age, parameters from Bayley-III-NL are
used as indicators of neurocognitive development. First,
the relation between the visual assessment parameters
and Bayley-III-NL parameters of the cognitive composite
score, the language composite score, and the motor
composite score will be analyzed using Pearson and
Spearman correlation analyses. Next, univariate ANOVA’s
are used to analyze differences in Bayley-III-NL scores
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between preterm children without a risk of VPD and
children at risk of VPD, and between preterm children at
risk of VPD in the direct versus the postponed inter-
vention group.
Monitoring
Data monitoring and auditing
The risks of our study for patients and for scientific
quality have both been judged as negligible, based on the
NFU risk classification (Netherlands Federation of
University Medical Centers). This risk level implies that
monitoring should be done once a year. Monitoring
involves:
– Study documents and agreements




– Clinical data management system
– Correct saving of raw data, corrected data, and
backups
Harms
In accordance with section 10, subsection 4 of the Wet
Medisch-wetenschappelijk Onderzoek met mensen
(WMO), the sponsor will suspend the study if there is
sufficient ground that continuation of the study will
jeopardize subject health or safety. The sponsor will no-
tify the accredited Medical Ethical Testing Committee
(METC) without undue delay of a temporary halt in-
cluding the reason for such an action. The study will be
suspended pending a further positive decision by the
accredited METC. The investigator will take care that all
subjects are kept informed.
Ethics and dissemination
The present study has been approved by the METC of
Erasmus Medical Center, Rotterdam (MEC-2016-724),
on April 19, 2017. Important protocol modifications
have been and will be communicated with the METC
(in the form of amendments to the original protocol),
project employees/researchers, and participating parents.
Written informed consent will be obtained by the re-
searchers before the baseline assessment, based on a
comprehensive information document that the potential
participants have received. See Additional file 2 for a
model consent form.
Participant confidentiality will be protected through
our data management policy (see section Data Manage-
ment). The main investigator(s) and the participating
medical and clinical specialists will have access to the
final trial dataset. There are no contractual agreements
that limit such access for investigators. During the
course of the study, the principal investigator will have
no access to patient-identifying data and communication
will only be done using participant codes. The involved
researchers and sponsors have no financial or other
competing interests for the overall trial nor for each
study site. No harm is expected from trial participation,
in particular since most study components are part of
standard clinical care. Therefore, ancillary and post-trial
care are suspected to be non-applicable.
Nature and extent of the burden, risks and benefits
associated with participation
The risks associated with participation are negligible and
the burden for the children is minimal. Apart from the
visual assessment from 1 year CA onwards, the total pro-
gram is standard care for children with (suspected) vis-
ual problems. Only the age at which this care is applied
is advanced for this study, and the visual rehabilitation
protocol has been structured in order to enable compari-
sons between children. There is a general burden for
children to perform the study-specific assessments and
for parents to accompany their children. A specific bur-
den for parents of children in the intervention groups is
the time and effort they are asked to invest in monitor-
ing and logging the child’s daily practices in the home
environment. Benefits for all preterm children are earlier
visual assessments, general developmental support and,
if applicable, earlier habilitation of a risk of VPD than is
the case in conventional pediatric care (i.e., from 1 to 2
years CA instead of ~ 4 years CA).
Dissemination policy
Dissemination of the results will include publications in
peer-reviewed scientific journals and use of the visual as-
sessments and the intervention protocol in clinical prac-
tice. There are no restrictions in the publication policy.
The investigators aim to publish all results obtained
from the study unreservedly.
Authorship guidelines
Our study adheres to the Research Code of Erasmus MC
in which guidelines for publishing and authorships are
defined (https://www6.erasmusmc.nl/cs-research/bijla-
gen/publiceren?reason=404).
Plans for granting public access to full protocol, dataset
and statistical code
Public access to the full protocol will be given through
this paper. All results will be published open access. The
dataset will not be made publicly available given the pa-
tient identifying information it contains. Statistical code
will be made available upon request.
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Discussion
The aim of this RCT is to investigate the effectiveness of
an innovative and comprehensive visual intervention
program for children with (a risk of) VPD from 1 year of
age. We have developed a visual intervention protocol
that adheres to recent scientific insights regarding habili-
tation and that exploits clinical expertise from visual re-
habilitation centers in the Netherlands.
The present study provides a solution to some notori-
ous problems in the (early) visual intervention domain.
Firstly, an underlying problematic paradox in the execu-
tion of intervention studies is that the content of visual
habilitation has to be tailored to the individual child in
order to exert effects, but that establishing scientific evi-
dence for effectiveness requires structured and con-
trolled designs with homogeneous groups. With this
protocol, we can achieve visual habilitation that is not
only structured and evidence based, but also individually
tailored and adaptive to a child’s level of functioning.
Parts of the general visual protocol are currently used in
visual practice but they have never been structured into
one comprehensive protocol, and have never been the
subject of scientific investigation. Since there is a lack of
evidence-based visual intervention or training programs
[20, 22], but clinical experiences are positive, these pro-
grams are considered best clinical practice. In addition,
the supplement visual protocol and additional compo-
nents were specifically designed for this study and satisfy
the need for individually adaptive programs. Secondly, in
order to obtain true evidence for the effects (does im-
provement occur as a result of the intervention or as re-
sult of ‘normal’ visual development?) an RCT is needed
in which children with visual dysfunctions are randomly
allocated to an intervention or control group. However,
a difficulty with conducting RCTs in (young) patient
groups is the ethical consideration regarding
randomization of treatment allocation, which means that
one group is withheld treatment. Our RCT design cir-
cumvents this problem. We start with providing inter-
vention to all participants a couple of years earlier than
is currently feasible within clinical visual care (from
about 4 years of age). That way, both the intervention
(from 1 year of age) and control group (from 2 years of
age) will receive earlier care than usual and therefore are
both expected to benefit from participation in this study.
This study has the potential to satisfy a great clinical
and scientific need for early and evidence-based visual
intervention options. To date, several reviews of visual
interventions in children mentioned a lack of evidence-
based programs. One showed some evidence for visual
training as opposed to, more passive, visual stimulation
[20]. Another focused on several strategies for visual im-
provement in children with frequently co-occurring vis-
ual and neurodevelopmental problems [22]. The
strongest evidence was found for visual aids (e.g.,
spectacles) and environmental modification to compen-
sate for visual loss. Less evidence was found for func-
tional behavioral methods that focused on actually
improving visual function, and it was stressed that more
information on this subject is needed. Given the increas-
ing prevalence of children with corrected low vision, i.e.,
for whom spectacles cannot provide more functional vis-
ual improvement, the availability of behavioral training
programs is of the utmost importance.
It is important to note that the present study not only
concerns early habilitation but also early screening of a
VPD risk. A combined approach of detecting and habili-
tating VPD in children will benefit from the multi-
disciplinary collaboration of involved neuroscientists,
neuropsychologists, and behavioral therapists. Upon
achieving the study goals, this set-up also ensures imme-
diate dissemination in the form of clinical implementa-
tion of the visual intervention program. The proposed
training programs contain a unique combination of ele-
ments that ensures incorporation of a widely advocated
system approach [38, 46]. This may not only improve
VPD and their development, but also support the par-
ent–infant relationship and improve infant self-
regulation and later independence. Through the imple-
mentation of this new program, we expect that more
children will gain opportunities for learning, develop-
ment, and daily independence earlier in life. These are
invaluable and essential steps toward an inclusive society
that maximizes children’s opportunities.
The broader scope of this new intervention program
lies in monitoring and supporting the development of
children at risk, not only in the visual domain but also
in behavioral, cognitive, and social-emotional domains.
Focusing our attention on the early development of chil-
dren born preterm will help set proper circumstances
for further learning and development up to school age.
Ultimately, we expect the outcomes to be applicable in
all types of pediatric patients at risk of VPD (e.g., comor-
bid with syndromes or developmental disorders). The
possibility to train visual functioning brings us closer to
enhancing neurodevelopment in prevalent neurological
risk groups and will optimize recovery or compensation
on a functional and daily level.
Study design challenges and limitations
An important challenge is to determine the right age to
start interventions – how early is too early? This is yet
unknown, which is why we chose to start at 1 year CA
when basic visual and neurological development has
completed and more developmental processes emerge.
We expect that careful monitoring of visual assessment
outcomes, not only related to interventions but also in
the placebo control group and in the form of yearly
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follow-up measurements, will reveal the age(s) at which
children start to show specific VPD. This will inform fu-
ture clinical applications or new studies about the ideal
developmental stages to start visual intervention pro-
grams. In addition, it was difficult to estimate the risk of
VPD in this specific population of children born < 30
weeks at 1 year CA. The precise number will determine
the inclusion and sample size of the intervention leg of
the study. However, besides investigating effectiveness of
visual intervention in children born preterm, the present
protocol provides a solid basis for other studies and/or
applications in different pediatric populations at risk of
VPD early in life. Lastly, the study population is a rela-
tively vulnerable risk group, particularly because of their
young age. Children born very or extremely preterm
generally go through a rough first start in the neonatal
period, putting a medical and psychological burden on
both the children and their parents. Therefore, we start
recruiting at 1 year of CA when, for the majority of chil-
dren, the most intense medical issues are behind them
and caregivers may be open to exploring new develop-
mental possibilities.
Trial status
Protocol version number and date: 5, 19 April 2017.
Date recruitment began: 20 April 2017.
Date recruitment for visual screening completed: 1
June 2018.
Date recruitment for (direct and postponed) rehabilita-
tion is estimated to be completed: 1 September 2019.
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